In today’s competitive pharmaceutical and nutraceutical market, speed-to-market and strong formulations matter more than ever. Development teams are under pressure to deliver high-quality, scalable products while working through complex regulatory requirements and changing consumer expectations. To meet these demands, scientists are turning to advanced technical tools that make development, scale up and manufacture more efficient, reduce uncertainty and support better decision-making.
Solutions such as HyperStart C2C®, Compatilus™ and Stablus are changing how teams approach product development and commercialization. Instead of relying mainly on trial and error, they help move development toward a more predictive, data-driven way of working.
Formulation development involves balancing a lot of moving parts: API properties, excipient compatibility, manufacturing processes, packaging choices and stability outcomes. This process can be:
When instability, incompatibility or processing issues show up late in development, the result can be costly reformulation work or delays to product launch.
HyperStart C2C is designed to give formulation development a faster start, helping scientists quickly identify viable starting points.
By taking much of the uncertainty out of early development, HyperStart C2C helps teams focus their time on optimization rather than exploration.
Compatilus is more than a program. It’s a full-service approach that combines pre-validation, technical support and line optimization guidance to help reduce risk and improve production performance.
How it works: test, validate, optimize, deploy. Compatilus supports trials on equipment, performance validation, machine adjustment and deployment support, helping customers move from compatibility to performance with fewer barriers.
By bringing stability considerations earlier into development, Stablus helps teams build robustness into their formulations from the start.
On their own, each tool delivers value. Used together, they create a connected approach that supports the whole journey from formulation to commercial manufacturing:
This integrated approach helps formulation teams move faster from development to commercialization, reduce reliance on iterative testing and make more confident, evidence-based decisions.
By adopting advanced technical tools like HyperStart C2C, Compatilus and Stablus, organizations can achieve:
| Speed |
|
| Efficiency |
|
| Confidence |
|
| Quality |
|
As the pharmaceutical industry continues to evolve, digitalization and predictive tools will play a bigger role in shaping development strategies. The move toward smarter, knowledge-based formulation is already underway and teams that embrace it will be better placed to innovate and compete.
HyperStart C2C, Compatilus and Stablus, reflect this new approach, helping scientists work more efficiently, reducing uncertainty and delivering better products to market, faster. Contact us today to learn more.
What are HyperStart C2C, Compatilus, and Stablus?
They’re advanced technical tools designed to support formulation and manufacturing development by improving speed, predictability and decision-making.
How do these tools help speed up formulation development?
They provide data-driven insights and starting points that reduce trial-and-error testing and help teams move faster from concept to prototype.
How can they help reduce formulation and production risk?
They help teams identify potential development, stability, or equipment integration challenges earlier, so risks can be addressed before they become costly delays.
At what stage of development are these tools most useful?
They’re especially valuable in early formulation development, but they can also support optimization, troubleshooting and long-term stability planning.
What is the main benefit for development and production teams?
The main benefit is greater confidence. Teams can make faster, smarter decisions while improving efficiency, robustness and readiness for scale-up or deployment.